J
Jason Park
Researcher at Yale University
Publications - 18
Citations - 5293
Jason Park is an academic researcher from Yale University. The author has contributed to research in topics: Immunotherapy & Transforming growth factor beta. The author has an hindex of 12, co-authored 18 publications receiving 3280 citations.
Papers
More filters
Journal ArticleDOI
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell,José Pedro Friedmann Angeli,Hülya Bayır,Ashley I. Bush,Marcus Conrad,Scott J. Dixon,Simone Fulda,Susan Gascon,Stavroula K. Hatzios,Valerian E. Kagan,Kay Noel,Xuejun Jiang,Andreas Linkermann,Maureen E. Murphy,Michael Overholtzer,Atsushi Oyagi,Gabriela Carolina Pagnussat,Jason Park,Qitao Ran,Craig S. Rosenfeld,Konstantin Salnikow,Daolin Tang,Daolin Tang,Frank M. Torti,Suzy V. Torti,Shinya Toyokuni,K. A. Woerpel,Donna D. Zhang +27 more
TL;DR: The mechanisms underlying ferroptosis are reviewed, connections to other areas of biology and medicine are highlighted, and tools and guidelines for studying this emerging form of regulated cell death are recommended.
Journal ArticleDOI
Label-free biomarker detection from whole blood.
Eric Stern,Aleksandar Vacic,Nitin K. Rajan,Jason M. Criscione,Jason Park,Bojan Ilic,David J. Mooney,Mark A. Reed,Tarek M. Fahmy +8 more
TL;DR: This work shows specific and quantitative detection of two model cancer antigens from a 10 uL sample of whole blood in less than 20 minutes and reduces its minimum required sensitivity by effectively pre-concentrating the biomarkers.
Journal ArticleDOI
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park,Stephen H. Wrzesinski,Stephen H. Wrzesinski,Eric Stern,Michael Look,Jason M. Criscione,Ragy Ragheb,Steven M. Jay,Stacey L. Demento,Atu Agawu,Paula Licona Limon,Anthony F. Ferrandino,David Gonzalez,Ann Habermann,Richard A. Flavell,Richard A. Flavell,Tarek M. Fahmy,Tarek M. Fahmy +17 more
TL;DR: N nanoscale liposomal polymeric gels (nanolipogels; nLGs) of drug-complexed cyclodextrins and cytokine-encapsulating biodegradable polymers that can deliver small hydrophobic molecular inhibitors and water-soluble protein cytokines in a sustained fashion to the tumour microenvironment significantly delayed tumour growth and increased survival of tumour-bearing mice.
Journal ArticleDOI
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Jason Park,Peter Fong,Jing Lu,Kerry S. Russell,Carmen J. Booth,W. Mark Saltzman,Tarek M. Fahmy +6 more
TL;DR: It is hypothesized that the efficacy of doxorubicin (DOX) can be maximized and dose-limiting cardiotoxicity minimized by controlled release from PEGylated nanoparticles.
Journal ArticleDOI
Modulation of CD4+ T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery
TL;DR: This targeted nanoparticle approach is able to harness endogenous immune-regulatory pathways, providing a powerful new method to modulating T cell developmental plasticity in immune-mediated disease indications.